KIT and breast cancer: Whereas studies in breast cancer cells have indicated that HIF-1α crucially regulates expression of stem cell factor (SCF), a c-KIT ligand [48], results on small-cell lung cancer cells indicated that activated SCF-c-KIT stimulated HIF-1α-mediated VEGF expression via PI3K/Akt activation [49].